Combination of Cetuximab and Oncolytic Virus Canerpaturev Synergistically Inhibits Human Colorectal Cancer Growth

The naturally occurring oncolytic herpes simplex virus canerpaturev (C-REV), formerly HF10, proved its therapeutic efficacy and safety in multiple clinical trials against melanoma, pancreatic, breast, and head and neck cancers. Meanwhile, patients with colorectal cancer, which has increased in preva...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Mol Ther Oncolytics
Main Authors: Wu, Zhiwen, Ichinose, Toru, Naoe, Yoshinori, Matsumura, Shigeru, Villalobos, Itzel Bustos, Eissa, Ibrahim Ragab, Yamada, Suguru, Miyajima, Noriyuki, Morimoto, Daishi, Mukoyama, Nobuaki, Nishikawa, Yoko, Koide, Yusuke, Kodera, Yasuhiro, Tanaka, Maki, Kasuya, Hideki
Format: Artigo
Jezik:Inglês
Izdano: American Society of Gene & Cell Therapy 2019
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6539424/
https://ncbi.nlm.nih.gov/pubmed/31193737
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.omto.2019.04.004
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki